Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MANEVeradermics, Inc

NYSE · CIK 0001827635
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts153

Identity from submissions API

NameVeradermics, Inc
CIK0001827635
TickersMANE
ExchangesNYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN843304423
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone228.372.3376
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
470 JAMES STREET
NEW HAVEN
CT
06513
CT
Mailing address
470 JAMES STREET
NEW HAVEN
CT
06513
CT

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

104 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-461091 005-95484 261554302 34 22377
2026-11-13 4 4 0001193125-26-461090 7711
2026-11-13 4 4 0001193125-26-461071 10304
2026-11-12 144 xsl144X01/primary_doc.xml 0001193125-26-457122 001-43097 261543717 33 5072
2026-11-10 10-Q 10-Q 0001827635-26-000043 001-43097 261541326 34 6926529 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001827635-26-000041 001-43097 261538282 34 641608 1 1
2026-11-09 8-K 8-K 7.01,8.01,9.01 0001827635-26-000038 001-43097 261534099 34 7954417 1 1
2026-10-19 8-K 8-K 7.01,8.01,9.01 0001827635-26-000036 001-43097 261467665 34 7437880 1 1
2026-10-13 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000019617-26-000348 005-95484 261456257 34 6753
2026-09-03 4 FORM 4 0001628280-26-060491 7455
2026-08-21 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000899140-26-000948 005-95484 261306016 34 35034
2026-08-21 4 FORM 4 0000899140-26-000947 41869
2026-08-20 3 FORM 3 0001628280-26-058305 11588
2026-08-19 144 xsl144X01/primary_doc.xml 0000899140-26-000905 001-43097 261296852 33 5284
2026-08-19 144 xsl144X01/primary_doc.xml 0000899140-26-000904 001-43097 261296849 33 5310
2026-08-18 4 FORM 4 0001628280-26-057816 15540
2026-08-18 4 FORM 4 0001628280-26-057813 15549
2026-08-17 144 xsl144X01/primary_doc.xml 0001968582-26-000850 001-43097 261287768 33 5366
2026-08-17 144 xsl144X01/primary_doc.xml 0001968582-26-000848 001-43097 261287732 33 5260
2026-08-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002672 333-298150 261284614 33 1783
2026-08-14 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001072613-26-000686 005-95484 261284398 34 143901
2026-08-14 144/A xsl144X01/primary_doc.xml 0001628280-26-057202 001-43097 261284221 33 4660
2026-08-14 4 FORM 4 0001628280-26-057196 10168
2026-08-14 424B3 424B3 0001628280-26-057174 333-298150 261283420 33 571263
2026-08-12 144 xsl144X01/primary_doc.xml 0001628280-26-056395 001-43097 261269102 33 4830
2026-08-12 144 xsl144X01/primary_doc.xml 0001628280-26-056391 001-43097 261269099 33 4758
2026-08-11 10-Q 10-Q 0001827635-26-000030 001-43097 261263899 34 6668299 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001827635-26-000028 001-43097 261260715 34 641730 1 1
2026-08-07 S-1 S-1 0001628280-26-054921 333-298150 261255325 33 886524 1 1
2026-08-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000315066-26-002159 005-95484 261247264 34 11350
2026-07-15 8-K 8-K 7.01,8.01,9.01 0001827635-26-000023 001-43097 261176056 34 6574002 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000905148-26-002434 005-95484 26990060 34 36589
2026-05-15 D xslFormDX01/primary_doc.xml 06b 0001827635-26-000020 021-584260 26985583 33 19768
2026-05-12 10-Q 10-Q 0001827635-26-000019 001-43097 26969735 34 5629995 1 1
2026-05-12 8-K 8-K 2.02,9.01 0001827635-26-000016 001-43097 26966019 34 626206 1 1
2026-05-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-057224 005-95484 26954311 34 27156
2026-05-05 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0000899140-26-000416 005-95484 26945543 34 16963
2026-05-05 4 xslF345X06/form4.xml 0000899140-26-000415 34769
2026-05-05 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-207186 005-95484 26945465 34 23515
2026-05-05 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001013594-26-000528 005-95484 26945316 34 29321
2026-05-05 3 FORM 3 0001013594-26-000527 5903
2026-05-01 8-K 8-K 1.01,3.02,9.01 0001628280-26-029376 001-43097 26933182 34 621869 1 1
2026-04-30 424B4 424B3 0001628280-26-029027 333-295356 26927431 33 2584115
2026-04-30 FWP FWP 0001628280-26-028546 333-295356 26919601 34 46638
2026-04-29 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001392 333-295356 26919629 33 1782
2026-04-29 S-1MEF S-1MEF 0001628280-26-028544 333-295420 26919545 33 314043 1 1
2026-04-27 FWP FWP 0001628280-26-027639 333-295356 26902258 34 46700
2026-04-27 CORRESP filename1.htm 0001628280-26-027635 10409
2026-04-27 CORRESP filename1.htm 0001628280-26-027634 17837
2026-04-27 S-1 S-1 0001628280-26-027631 333-295356 26902137 33 3402896 1 1
2026-04-27 8-K 8-K 2.02 0001628280-26-027629 001-43097 26902124 34 144137 1 1
2026-04-27 8-K 8-K 7.01,8.01,9.01 0001628280-26-027354 001-43097 26896873 34 6755319 1 1
2026-04-07 UPLOAD filename1.pdf 0000000000-26-003484 377-09225 40066
2026-04-06 DRS filename1.htm 0001628279-26-000454 377-09225 26840647 33 2532294
2026-03-30 10-K 10-K 0001827635-26-000013 001-43097 26813671 34 68899506 1 1
2026-03-30 8-K 8-K 2.02,9.01 0001827635-26-000010 001-43097 26810121 34 252803 1 1
2026-02-27 4/A FORM 4/A 0001027035-26-000004 5750
2026-02-12 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-049157 005-95484 26628047 34 151492
2026-02-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000905148-26-000680 005-95484 26627310 34 39972
2026-02-11 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0000899140-26-000173 005-95484 26622100 34 125556
2026-02-11 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-046658 005-95484 26621197 34 341056
2026-02-09 4 xslF345X05/form4.xml 0000899140-26-000140 75079
2026-02-09 3 xslF345X02/form3.xml 0000899140-26-000139 26150
2026-02-05 4 4 0001193125-26-039876 5175
2026-02-05 4 FORM 4 0001628280-26-005910 9105
2026-02-05 4 FORM 4 0001628280-26-005909 6125
2026-02-05 4 FORM 4 0001628280-26-005907 35530
2026-02-05 4 FORM 4 0001628280-26-005906 19544
2026-02-05 4 FORM 4 0001628280-26-005905 24784
2026-02-05 4 FORM 4 0001628280-26-005904 21701
2026-02-05 4 FORM 4 0001628280-26-005903 5540
2026-02-05 4 FORM 4 0001628280-26-005900 5610
2026-02-05 4 FORM 4 0001628280-26-005899 5609
2026-02-05 4 FORM 4 0001628280-26-005898 10511
2026-02-05 4 FORM 4 0001628280-26-005897 9347
2026-02-05 S-8 S-8 0001628280-26-005859 333-293238 26604001 33 415093 1 1
2026-02-05 8-K 8-K 5.03,9.01 0001628280-26-005800 001-43097 26603224 34 171512
2026-02-04 424B4 424B4 0001628280-26-005505 333-292657 26599354 33 37827005
2026-02-04 CERT NYSE CERTIFICATION 0000876661-26-000084 001-43097 26595936 34 384781
2026-02-03 3 3 0001193125-26-036425 24075
2026-02-03 3 FORM 3 0001628280-26-005249 12762
2026-02-03 3 FORM 3 0001628280-26-005248 11904
2026-02-03 3 FORM 3 0001628280-26-005247 22456
2026-02-03 3 FORM 3 0001628280-26-005246 16281
2026-02-03 3 FORM 3 0001628280-26-005245 13949
2026-02-03 3 FORM 3 0001628280-26-005244 16894
2026-02-03 3 FORM 3 0001628280-26-005243 7357
2026-02-03 3 FORM 3 0001628280-26-005242 14327
2026-02-03 3 FORM 3 0001628280-26-005241 18182
2026-02-03 3 FORM 3 0001628280-26-005240 24969
2026-02-03 3 FORM 3 0001628280-26-005239 23712
2026-02-03 S-1MEF S-1MEF 0001628280-26-005218 333-293180 26595575 33 274868 1 1
2026-02-03 8-A12B 8-A12B 0001628280-26-005106 001-43097 26594490 34 17930
2026-02-03 FWP FWP 0001827635-26-000005 333-292657 26589941 34 22525
2026-01-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000407 333-292657 26585552 33 1782
2026-01-28 S-1/A S-1/A 0001628280-26-003764 333-292657 26570273 33 41480854 1 1
2026-01-09 S-1 S-1 0001628280-26-001651 333-292657 26523842 33 38336763 1 1
2025-10-28 D xslFormDX01/primary_doc.xml 06b 0001231919-25-000361 021-562294 251424336 33 10982
2025-10-27 DRS filename1.htm 0001628279-25-000707 377-08614 251417292 33 6926316
2024-12-10 D xslFormDX01/primary_doc.xml 06b 0001827635-24-000001 021-531652 241538171 33 10925
2023-05-01 D xslFormDX01/primary_doc.xml 06b 0001827635-23-000002 021-480424 23870604 33 8918
2021-10-07 D/A xslFormDX01/primary_doc.xml 06b 0001827635-21-000004 021-415905 211312202 33 9431
2021-10-06 D xslFormDX01/primary_doc.xml 06b 0001827635-21-000003 021-415905 211309562 33 6822
2020-10-09 D xslFormDX01/primary_doc.xml 06b 0001827635-20-000001 021-377538 201232489 33 6666

Latest XBRL company facts

One latest value per concept from companyfacts (153 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 42.20M 2026-11-05 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
dei EntityPublicFloat Entity Public Float USD 0 2025-06-30 2025 FY 10-K 2026-03-30 0001827635-26-000013
ffd NetFeeAmt NetFeeAmt USD 234,326.95 2026-08-07 S-1 2026-08-07 0001628280-26-054921
ffd TtlFeeAmt TtlFeeAmt USD 234,326.95 2026-08-07 S-1 2026-08-07 0001628280-26-054921
ffd TtlOfferingAmt TtlOfferingAmt USD 1.70B 2026-08-07 S-1 2026-08-07 0001628280-26-054921
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-07 S-1 2026-08-07 0001628280-26-054921
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-07 S-1 2026-08-07 0001628280-26-054921
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.91M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 1.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 1.96M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 8.16M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 2.65M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -3.05M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 994.68M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 4.09M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 12.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 5.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 1,202 2025-03-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap Assets Assets USD 807.22M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AssetsCurrent Assets, Current USD 805.78M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AssetsNoncurrent Assets, Noncurrent USD 1.43M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 798.76M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 USD 0 2026-03-31 2026 Q1 10-Q 2026-05-12 0001827635-26-000019
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 USD 0 2026-03-31 2026 Q1 10-Q 2026-05-12 0001827635-26-000019
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 217.06M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 215.08M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 USD 0 2026-03-31 2026 Q1 10-Q 2026-05-12 0001827635-26-000019
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 USD 0 2026-03-31 2026 Q1 10-Q 2026-05-12 0001827635-26-000019
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value USD 795.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 581.69M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 580.63M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 666.19M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 132.16M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 798.40M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 132.16M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 110.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0 2026-05-31 2026 Q2 10-Q 2026-08-11 0001827635-26-000030
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 42.19M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 42.19M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -74.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss USD 4.70M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD -3.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 770.20M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap DeferredCostsCurrent Deferred Costs, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 6.76M 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 24.27M 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 187,000 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 4.72M 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 522,000 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 36.46M 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.12 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.242 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.059 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.035 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 16.60M 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 32.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -71.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 1.21M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 16.96M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -14.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 219,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -212,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 3.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 1.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 406,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -38,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -3.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 25,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 12.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap Liabilities Liabilities USD 10.74M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 807.22M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap LiabilitiesCurrent Liabilities, Current USD 10.37M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 713.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -544.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -58.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -71.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -74.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -74.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 16.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap NotesIssued1 Notes Issued USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap OperatingExpenses Operating Expenses USD 88.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -88.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 371,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.04M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 180.30M 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.77M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap OtherAssetsCurrent Other Assets, Current USD 602,000 2026-03-31 2026 Q1 10-Q 2026-05-12 0001827635-26-000019
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -3.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -3.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 297,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -108,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 4.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 1.25M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 27.70M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 638.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 367,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 25.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 7.43M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap PrepaidInsurance Prepaid Insurance USD 362,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 269.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 414.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 28.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 94.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 386,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 800,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 55.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -195.15M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 694,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 151.00M 2025-10-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 12.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.847 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.77 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.045 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.036 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 796.47M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.099 2026-01-27 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD 596,000 2026-06-30 2026 Q2 10-Q 2026-08-11 0001827635-26-000030
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 300,000 2026-08-01 2026-08-31 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 264.48M 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 414.33M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.33M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap TemporaryEquitySharesSubscribedButUnissuedSubscriptionsReceivable Temporary Equity, Shares Subscribed but Unissued, Subscriptions Receivable USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 21.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001827635-26-000013
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 35.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 35.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001827635-26-000043

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →